Efficacy of platelet concentrates in bone healing: A systematic review on animal studies - Part B: Large-size animal models.

Abstract:

:In the presence of large bone defects, delayed bone union, or nonunion and fractures, bone reconstruction may be necessary. Different strategies have been employed to enhance bone healing among which the use of autologous platelet concentrates (APCs). Due to the high content of platelets and platelet-derived bioactive molecules (e.g., growth factors, antimicrobial peptides), they are promising candidates to enhance bone healing. However, both preclinical and clinical studies produced contrasting results, mainly due to a high heterogeneity in study design, objectives, techniques adopted, and outcomes assessed. The aim of the present systematic review was to evaluate the efficacy of APCs in animal models of bone regeneration, considering the possible factors that might affect the outcome. An electronic search was performed on MEDLINE and Scopus databases. Comparative animal studies with a minimum follow up of 2 weeks, at least five subjects per group and using APCs for regeneration of bone defects were included. Articles underwent risk of bias assessment and quality evaluation. Fifty studies performed on six animal species (rat, rabbit, dog, sheep, goat, mini-pig) were included. The present part of the review considers studies performed on small ruminants, dogs, and mini-pigs (14 articles). The majority of the studies were considered at low risk of bias. In general, APCs' adjunct positively affected bone regeneration. Animal species, platelet and growth factors concentration, type of bone defect and of platelet concentrate used seemed to influence their efficacy in bone healing. However, sound conclusions were not drawn since too few studies for each large-size animal model were included. In addition, characterization of APCs' content was performed only in a few studies. Further studies with a standardized protocol including characterization of the final products will provide useful information for translating the results to clinical application of APCs in bone surgery.

journal_name

Platelets

journal_title

Platelets

authors

Marcazzan S,Taschieri S,Weinstein RL,Del Fabbro M

doi

10.1080/09537104.2017.1384537

subject

Has Abstract

pub_date

2018-06-01 00:00:00

pages

338-346

issue

4

eissn

0953-7104

issn

1369-1635

journal_volume

29

pub_type

杂志文章,评审
  • Functional interaction of carbonic anhydrase and chloride/bicarbonate exchange in human platelets.

    abstract::Recently, our laboratory has reported the presence of one acidifying Cl-/HC exchange mechanism in human platelets. This paper demonstrates that this exchanger decreases its activity after inhibition of carbonic anhydrase. BCECF-loaded platelets, previously equilibrated in a bicarbonate/CO2 buffered solution, were resu...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100500163457

    authors: Gende OA

    更新日期:2005-11-01 00:00:00

  • Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.

    abstract::The purpose of the study was to evaluate safety, effects on platelet aggregation and pharmacokinetics of F(ab')(2) fragments of anti-glycoprotein (GP) IIb-IIIa murine monoclonal antibody FRaMon (F(ab')(2) FRaMon) upon its intravenous administration in patients undergoing high-risk coronary angioplasty. Patients were t...

    journal_title:Platelets

    pub_type: 临床试验,杂志文章

    doi:10.1080/0953710021000057839

    authors: Mazurov AV,Pevzner DV,Antonova OA,Byzova TV,Khaspekova SG,Semenov AV,Vlasik TN,Samko AN,Staroverov II,Ruda MY

    更新日期:2002-12-01 00:00:00

  • Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database.

    abstract::The aim of this survey was to describe drug-induced immune thrombocytopenia (ITP) reported in the French PharmacoVigilance database (FPVD) and to discuss the drugs involved. The request to the FPVD used the seven most accurate diagnosis codes to identify ITP. The study was restricted to cases reported from 2007 to 201...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2011.633179

    authors: Moulis G,Sommet A,Sailler L,Lapeyre-Mestre M,Montastruc JL,French Association Of Regional Pharmacovigilance Centers.

    更新日期:2012-01-01 00:00:00

  • Platelet activation in subjects with impaired glucose tolerance.

    abstract::Impaired glucose tolerance (IGT), a prediabetic state, is associated with an increased risk of cardiovascular disease. Mean platelet volume (MPV), a determinant of platelet activation, is a newly emerging risk factor for atherothrombosis. This study was designed to answer the following questions: (i) Do MPV levels cha...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100701609019

    authors: Coban E,Kucuktag S,Basyigit S

    更新日期:2007-12-01 00:00:00

  • Role of reactive nitrogen species in blood platelet functions.

    abstract::Blood platelets, in analogy to other circulating blood cells, can generate reactive oxygen/nitrogen species (ROS/RNS) that may behave as second messengers and may regulate platelet functions. Accumulating evidence suggest a role of ROS/RNS in platelet activation. On the other hand, an increased production of ROS/RNS c...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.1080/09537100701504087

    authors: Olas B,Wachowicz B

    更新日期:2007-12-01 00:00:00

  • Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.

    abstract::Patients with peripheral artery disease (PAD) following peripheral percutaneous transluminal angioplasty (PTA) with stent implantation are prone to stent thrombosis despite treatment with aspirin and clopidogrel. Impaired clopidogrel responsiveness is associated with increased risk of ischemic events in patients follo...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2012.676220

    authors: Mazur P,Frołow M,Niżankowski R,Sadowski J,Undas A

    更新日期:2013-01-01 00:00:00

  • Release of Choline Metabolites from Human Platelets: Evidence for Activation of Phospholipase D and of Phosphatidylcholine-specific Phospholipase C.

    abstract::In aspirin-treated platelets labelled by preincubation with [(3)H]-choline, enhanced release of both [(3)H]-choline and [(3)H]-choline phosphate resulted from stimulation by collagen or thrombin. No such release accompanied stimulation by ADP, platelet-activating factor or adrenaline. Release of [(3)H]-choline phospha...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109309013192

    authors: Petty AC,Scrutton MC

    更新日期:1993-01-01 00:00:00

  • Medium on-treatment platelet reactivity to ADP is favorable in patients with acute coronary syndromes undergoing coronary stenting.

    abstract::Bleeding in the setting of acute coronary syndromes (ACS) has negative prognostic implications. We sought to determine the impact of different levels of on-treatment platelet reactivity (PR) to ADP on both bleeding and ischemic events in ACS patients receiving coronary stenting. PR to ADP was measured with the VerifyN...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2011.568075

    authors: Huczek Z,Filipiak KJ,Kochman J,Michalak M,Roik M,Grabowski M,Opolski G

    更新日期:2011-01-01 00:00:00

  • The cellular basis of platelet secretion: Emerging structure/function relationships.

    abstract::Platelet activation has long been known to be accompanied by secretion from at least three types of compartments. These include dense granules, the major source of small molecules; α-granules, the major protein storage organelle; and lysosomes, the site of acid hydrolase storage. Despite ~60 years of research, there a...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.1080/09537104.2016.1257786

    authors: Yadav S,Storrie B

    更新日期:2017-03-01 00:00:00

  • Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.

    abstract::In adults with immune thrombocytopenic purpura (ITP), steroids are usually proposed as first-line therapy, but long-term complete responses are obtained in no more than 20% of patients. For the remaining patients, splenectomy is considered the treatment of choice, with reported "cure" rates from 60-70%. However, the i...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100802315110

    authors: Vancine-Califani SM,De Paula EV,Ozelo MC,Orsi FL,Fabri DR,Annichino-Bizzacchi JM

    更新日期:2008-11-01 00:00:00

  • The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome.

    abstract::To test the role of platelet activation in the prognosis of nephrotic syndrome (NS), we evaluated the mean platelet volume (MPV) in patients with NS undergoing treatment. In this prospective, multicenter clinical study 156 patients with primary NS under treatment were assigned and followed for one year. Patients were ...

    journal_title:Platelets

    pub_type: 杂志文章,多中心研究

    doi:10.3109/09537104.2012.731111

    authors: Kocyigit I,Yilmaz MI,Simşek Y,Unal A,Sipahioglu MH,Eroglu E,Dede F,Tokgoz B,Oymak O,Utas C

    更新日期:2013-01-01 00:00:00

  • Risk factors and clinical outcome of profound thrombocytopenia in adult patients with DENV infections.

    abstract::Severe thrombocytopenia is common in dengue virus (DENV) infections. However, studies focusing on the role of profound thrombocytopenia (PT) (nadir platelet counts ≤ 20 000/mm3) in DENV infections are scarce. This study aims to identify the associated features and outcome of DENV patients with PT. It involves 237 adul...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2017.1293802

    authors: Dhanoa A,Rajasekaram G,Hassan SS,Ramadas A,Azreen Adnan NA,Lau CF,Chan TS,Ngim CF

    更新日期:2017-11-01 00:00:00

  • Comparison of the release of microRNAs and extracellular vesicles from platelets in response to different agonists.

    abstract::On activation platelets release microRNAs and extracellular vesicles (EV) into circulation. The release of EV from platelets has been shown to be dependent on the agonist; in this study, we investigated whether the microRNA profile or EV released from platelets was also agonist specific. Washed platelets from healthy ...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2017.1332366

    authors: Ambrose AR,Alsahli MA,Kurmani SA,Goodall AH

    更新日期:2018-07-01 00:00:00

  • Vigorous exercise as a triggering mechanism for late stent thrombosis: A description of three cases.

    abstract::Although (very) late coronary stent thrombosis is a rare complication after percutaneous coronary interventions (PCI), its consequences are devastating with a high morbidity and mortality. Previous studies have identified several clinical, procedural and angiographic characteristics that are associated with stent thro...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537100903388367

    authors: Zwart B,Van Kerkvoorde TC,van Werkum JW,Breet NJ,Ten Berg JM,Van 't Hof AW

    更新日期:2010-01-01 00:00:00

  • Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis.

    abstract::Recent studies have indicated that medical options without splenectomy, such as rituximab (RTX) or thrombopoietin receptor agonists (TPO-RAs), can be effective to treat persistent or chronic primary immune thrombocytopenia (ITP). However, it remains to be determined which of these strategies should be the first choice...

    journal_title:Platelets

    pub_type: 杂志文章,meta分析

    doi:10.1080/09537104.2018.1543864

    authors: Arai Y,Matsui H,Jo T,Kondo T,Takaori-Kondo A

    更新日期:2019-01-01 00:00:00

  • Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchange.

    abstract::Catastrophic antiphospholipid syndrome (CAPS) involves sudden multiorgan dysfunction from thrombosis due to antibodies that cause platelet activation and endothelial dysfunction. Treatment variably combines anticoagulation, corticosteroid use, therapeutic plasma exchange (TPE), and high-dose intravenous immunoglobulin...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2020.1802414

    authors: James TE,Martin LJ,Warkentin TE,Crowther MA

    更新日期:2020-08-07 00:00:00

  • von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets.

    abstract::Type 2B von Willebrand's disease (VWD) is an inherited bleeding disorder characterized by spontaneous binding of large von Willebrand factor (VWF) multimers to platelets in vivo. This phenomenon induces the clearance of both large multimers and platelets, usually resulting in thrombocytopenia with slightly increased p...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100500441150

    authors: Loffredo G,Baronciani L,Noris P,Menna F,Federici AB,Balduini CL

    更新日期:2006-05-01 00:00:00

  • Time dependent reduction in platelet aggregation using the multiplate analyser and hirudin blood due to platelet clumping.

    abstract::The Multiplate is a popular instrument that measures platelet function using whole blood. Potentially considered a point of care instrument, it is also used by hemostasis laboratories. The instrument is usually utilized to assess antiplatelet medication or as a screen of platelet function. According to the manufacture...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2017.1384540

    authors: Chapman K,Favaloro EJ

    更新日期:2018-05-01 00:00:00

  • Aging of platelets stored for transfusion.

    abstract::A goal of platelet storage is to maintain the quality of platelets from the point of donation to the point of transfusion - to suspend the aging process. This effort is judged by clinical and laboratory measures with varying degrees of success. Recent work gives encouragement that platelets can be maintained ex vivo b...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.3109/09537104.2016.1171303

    authors: Smethurst PA

    更新日期:2016-09-01 00:00:00

  • ATP does not affect fibrinogen binding to platelet GPIIbIIIa in systems free of signal transduction.

    abstract::Recent studies have suggested that the platelet fibrinogen (Fg) receptor, platelet membrane glycoprotein IIbIIIa (GPIIbIIIa, or integrin alpha(IIb)beta(3)) is also an adenosine triphosphate (ATP) binding site, and that the binding of ATP can directly inhibit the Fg-binding function of GPIIbIIIa. However, any direct ef...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537109975889

    authors: Liu Q,Sloan S,Frojmovic MM

    更新日期:1999-01-01 00:00:00

  • Association of platelet function in hypertensive patients with left ventricular hypertrophy, transient myocardial ischemia, and coronary artery disease.

    abstract::The aim of the study was to evaluate how platelet aggregation relates to left ventricular hypertrophy, presence of transient myocardial ischemia and coronary atherosclerosis in essential hypertensive patients. For that purpose platelet aggregation, symptom-limited treadmill-test, echocardiography and coronary angiogra...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537109876672

    authors: Gabbasov Z,Parfyonova Y,Popov E,Gavrilov I,Anuchin V,Dubov P,Djakonova Y

    更新日期:1998-01-01 00:00:00

  • A new variant of Glanzmann's thrombasthenia with defective activation-dependent fibrinogen binding and altered expression of epitopes for several monoclonal antibodies against GP IIb-IIIa.

    abstract::In a family, a moderate bleeding disorder in two patients has been specified as Glanzmann's thrombasthenia because of characteristic defects in platelet function. Analysis of platelet membrane glycoproteins revealed about a 50% decrease in the amount of GP IIb-IIIa complex (α(11b)β(3) integrin), which appeared normal ...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109609023581

    authors: Meyer M,Thieme A,Jablonka B,Just M,Ströhl C,Schellenberg I,Kirchmaier CM

    更新日期:1996-01-01 00:00:00

  • Effects of beta2-glycoprotein-I on platelet aggregation in cord versus adult whole blood.

    abstract::We present a peculiarity of the neonatal hemostatic system that might contribute to establish a procoagulant readiness in neonatal blood by sensitizing neonatal platelets for ADP stimulation. beta2-glycoprotein-I (beta2-GP-I) is a plasma constituent capable of suppressing ADP-induced platelet aggregation. We found sig...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100600800529

    authors: Cvirn G,Gallistl S,Koestenberger M,Kutschera J,Ferstl U,Kellner J,Jurgens G,Gries A

    更新日期:2007-02-01 00:00:00

  • Human platelet lysates for human cell propagation.

    abstract::A pathogen-free and standardized xeno-free supplement of growth media is required for the ex vivo propagation of human cells used as advanced therapeutic medicinal products and for clinical translation in regenerative medicine and cell therapies. Human platelet lysate (HPL) made from therapeutic-grade platelet concent...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2020.1849602

    authors: Barro L,Burnouf PA,Chou ML,Nebie O,Wu YW,Chen MS,Radosevic M,Knutson F,Burnouf T

    更新日期:2020-11-29 00:00:00

  • Thrombocytosis secondary to chronic lead poisoning.

    abstract::We report a case of total hyperpigmentation of the skin, severe itching, muscle weakness and thrombocytosis. Laboratory investigation showed white blood cell (WBC) 8.2 x 10(6)/L, Hb 125 g/L, platelets 1221 x 10(6)/L and urinary lead after DMSA mobilization test 2684 mcg/g creatinine (normal <5). Chelation therapy with...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537101003612813

    authors: Al Momen A

    更新日期:2010-01-01 00:00:00

  • A deleterious effect of aspirin on the antithrombotic properties of endothelial cells is not observed with platelets previously exposed to aspirin: studies in a flow system.

    abstract::We have explored both the independent and combined effects of aspirin on cultured endothelial cells and platelets, and its influence on platelet deposition onto an extracellular matrix. Blood was circulated through a flat perfusion chamber with two coverslips placed sequentially with respect to blood flow. The first c...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109609079506

    authors: Alemany M,Hernández MR,Bozzo J,Bono A,Escolar G,Ordinas A,Bastida E

    更新日期:1996-01-01 00:00:00

  • The mean platelet volume in subjects with impaired fasting glucose.

    abstract::Mean platelet volume (MPV), a determinant of platelet function, is a newly emerging risk factor for atherothrombosis. Impaired fasting glucose (IFG) is probably a frequent glycemic disorder in the general population and is considered as a prediabetic state. The present study was designed to evaluate MPV in subjects wi...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100500220729

    authors: Coban E,Bostan F,Ozdogan M

    更新日期:2006-02-01 00:00:00

  • Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention.

    abstract::In patients with acute coronary syndrome (ACS), treatment using ticagrelor demonstrated significant ischemic benefits over clopidogrel; however, it was associated with increased bleeding complications leading to frequent de-escalation to clopidogrel. The objective of the present study was to investigate the efficacy a...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2019.1609668

    authors: Wang C,Zheng W,Shaqdan A,Wang C,Qin X,Zhao X,Wang X,Yuan L,Nie S,Liu R

    更新日期:2020-01-01 00:00:00

  • Antibodies against complement-regulatory proteins on platelets in immune thrombocytopenia.

    abstract::In immune thrombocytopenia (ITP), antibodies reacting with platelet membrane glycoproteins (GP) mediate premature platelet cleavage, resulting in thrombocytopenia and therefore a risk of bleeding. These antibodies may induce complement activation, thus mediating complement-induced platelet destruction. In this study, ...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2016.1235686

    authors: Unterberger U,Eichelberger B,Ulz A,Panzer S

    更新日期:2017-06-01 00:00:00

  • The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.

    abstract::The aim of these studies was to investigate the extent of platelet P2Y(12) receptor inhibition by the thienopyridine active metabolite of prasugrel, R-138727. Blood was taken from healthy volunteers and pre-incubated with R-138727 or cangrelor (AR-C66931MX). Platelet aggregation was assessed in platelet rich plasma (P...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100701694144

    authors: Judge HM,Buckland RJ,Sugidachi A,Jakubowski JA,Storey RF

    更新日期:2008-03-01 00:00:00